Patent details

EP3340968 Title: IMPLANTABLE NALTREXONE TABLETS

Basic Information

Publication number:
EP3340968
PCT Application Number:
IN2016050280
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168386977
PCT Publication Number:
WO2017033208
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMPLANTABLE NALTREXONE TABLETS
French Title of Invention:
COMPRIMÉS IMPLANTABLES À BASE DE NALTREXONE
German Title of Invention:
IMPLANTIERBARE NALTREXON-TABLETTEN
SPC Number:

Dates

Filing date:
23/08/2016
Grant date:
01/06/2022
EP Publication Date:
04/07/2018
PCT Publication Date:
02/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/06/2022
EP B1 Publication Date:
01/06/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/08/2024
Expiration date:
23/08/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/05/2022
 
 

Name:
Rusan Pharma Limited
Address:
58-D, Government Industrial Estate Charkop Kandivali (West), Mumbai 400067, India (IN)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/06/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SAXENA, Kunal
Address:
India (IN)

2

Name:
SAXENA, Navin
Address:
India (IN)

Priority

Priority Number:
3223MU2015
Priority Date:
24/08/2015
Priority Country:
India (IN)

Classification

IPC classification:
A61K 9/22; A61K 9/16; A61K 31/485;

Publication

European Patent Bulletin

Issue number:
202222
Publication date:
01/06/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/08/2023
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
20/06/2022 Power Of Attorney 1
20/06/2022 Outgoing Correspondence 1